Continental Clinical Solutions
Script error: No such module "AfC submission catcheck".
Continental Clinical Solutions is an American independent life sciences research organization headquartered in Towson, Maryland.[1][2] It conducts clinical trials and medical research on behalf of pharmaceutical companies to assist drugs and new therapies pass through the FDA approval process.[3] Its current CEO is Saleh Stevens.[4][5]
History[edit]
Continental was branded as Continental Clinical Solutions in 2012, with its initial focus on recruiting underserved populations into clinical research.[6] After partnering with DSCS a California-based Site management organization, in 2014, Continental expanded its network to include sites across the U.S.[7] It has broached foreign expansion in developing markets, including India and northern Africa.[8] It claims to focus primarily on Phase II-IV clinical trials and associated ancillary services throughout most therapeutic areas[9] and currently consults for trial expansion on small international studies and is one of the 25 US sites working on the treatment for Human Pampiloma virus 16 and 18.[10][11]
References[edit]
- ↑ Lindner, Linda (10 January 2022). "Continental Clinical Solutions signs long-term medical office lease in Cherry Hill". ROI-NJ.
- ↑ "Continental Clinical Solutions LLC - Company Profile and News". Bloomberg News.
- ↑ "Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV". ClinicalTrials.gov. 6 December 2021.
- ↑ "Continental Clinical Solutions Brings Clinical Studies to More Diverse Patient Populations". HuffPost. 7 July 2016.
- ↑ "AOBiome Pruritus-Eczema (Itch) Clinical Study". AOBiome.
- ↑ "Feb 2018 Newsletter". www.marshall.usc.edu. University of Southern California.
- ↑ "Clinical Trial on Sexually Transmitted Diseases: EVO100, Placebo - Clinical Trials Registry - ICH GCP". ichgcp.net. Evofem Inc.
- ↑ "The Lack of Diversity in Clinical Studies Is Alarmingly Dangerous". HuffPost. 6 June 2016.
- ↑ "Clinical Trial on Leiomyoma: Vilaprisan (BAY1002670), Vilaprisan (BAY1002670), Vilaprisan (BAY1002670), Standard of care, Vilaprisan (BAY1002670), Vilaprisan (BAY1002670), Vilaprisan (BAY1002670)". ichgcp.net.
- ↑ "Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids". clinicaltrials.gov. 29 April 2022.
- ↑ "Prism Capital Partners' redevelopment at Dunellen Station reaches construction milestone". ROI-NJ. 10 January 2022.
Coordinates: 39°23′25″N 76°36′15″W / 39.3904°N 76.6041°W
This article "Continental Clinical Solutions" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Continental Clinical Solutions. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
